Jones Financial Companies’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
43,291
+11,863
+38% +$578K ﹤0.01% 1500
2026
Q1
$1.31M Buy
31,428
+26,651
+558% +$1.15M ﹤0.01% 1612
2025
Q4
$209K Sell
4,777
-4,700
-50% -$194K ﹤0.01% 1889
2025
Q3
$370K Buy
9,477
+6,089
+180% +$245K ﹤0.01% 1519
2025
Q2
$148K Buy
3,388
+985
+41% +$39.4K ﹤0.01% 1776
2025
Q1
$88.2K Buy
2,403
+1,837
+325% +$65.5K ﹤0.01% 1834
2024
Q4
$18.8K Buy
566
+271
+92% +$8.79K ﹤0.01% 2283
2024
Q3
$7.66K Buy
295
+200
+211% +$4.97K ﹤0.01% 2314
2024
Q2
$2.13K Buy
+95
New +$2.11K ﹤0.01% 2145

Other funds holding EXEL

Jones Financial Companies's EXEL Position: Q2 2026 in Review

Jones Financial Companies increased its Exelixis (EXEL) stake by 38% in Q2 2026, buying an estimated $578K and bringing the position to 43,291 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

Jones Financial Companies first reported a position in EXEL in Q2 2024 and has held it in 9 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Jones Financial Companies held 43,291 shares of Exelixis worth $2.37M as of Q2 2026.
  • Jones Financial Companies bought 11,863 Exelixis shares in Q2 2026, an estimated $578K.
  • Exelixis made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1500 holding.
  • Jones Financial Companies first reported a position in Exelixis in Q2 2024 and has held it in 9 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.